Trial intelligence / Profile preview

Pilocarpine-induced morphological changes in high myopia and glaucoma

NCT05352854Unknown

Start
May 2022
Primary completion
Jun 2022
Modality
Small Molecules
01

Overview

Open-label trial of pilocarpine in Glaucoma (4 arms). Primary endpoints: Morphology of ciliary body at 40 minutes and Morphology of trabecular meshwork at 40 minutes. Status: unknown.

02

Drugs

pilocarpine
03

Conditions

Glaucoma

Beyond the preview

Go deeper on NCT05352854.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05352854.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call